Clinical Trial Update: Study to Investigate the Health Benefits of a Quercetin/Curcumin-Based Supplement for Mild to Moderate Long COVID-19 Symptoms [NA]

View source ↗

Summary

A completed clinical trial assessed the health benefits of a quercetin/curcumin-based supplement for mild-to-moderate Long COVID symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Quercetin/Curcumin-based supplement

Snippet

Sponsor: Liaquat University of Medical & Health Sciences | Conditions: Long COVID | NA | Status: COMPLETED